Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-07-09

Clinical Trial Update: Intestinal Microbiome Composition in Infants With Biliary Atresia (BA)

View source ↗

Summary

A clinical trial evaluating intestinal microbiome composition in infants with biliary atresia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Biliary Atresia, Intrahepatic Cholestases | Status: WITHDRAWN